Patient signature exemption extended to 30 June

The temporary suspension of the need for patients in England (or their representatives) to sign the back of NHS prescriptions or EPS tokens has been extended for a further 3 months until June 30.

Whilst the suspension of signature requirements remains in place, contractors are not required to submit EPS tokens other than those used for SSP claims to the NHS Business Services Authority (NHSBSA).

The suspension was initially introduced for a period of 5 months up to 31 March as a temporary measure to limit the transmission of coronavirus by avoiding cross contamination and to minimise the handling of paperwork when collecting medicines.

The suspension will be kept under review and may be extended again if there continues to be a cross infection risk, or removed as soon as it is deemed safe for patients to resume signing forms, says NHS England.

  • The NHS prescription charge increases today (1 April) from £9.15 to £9.35 per item. The cost of prepayment certificates also goes up: a three month PPC now costs £30.25 and the 12 month PPC is £108.10.
  • The Pandemic Delivery Service for clinically extremely vulnerable (CEV) patients finished on 31 March.
  • The community pharmacy Flu Vaccination Service 2020/21 also finished on 31 March. Claims for vaccinations will be accepted by NHSBSA via the Manage Your Service (MYS) platform within six months of administration of the vaccination or by 31 August, whichever date is earlier.

Comments (0)

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.